<DOC>
	<DOCNO>NCT00150761</DOCNO>
	<brief_summary>Phase IV , human pharmacology , exploratory , randomize , 3-way ( 3 treatment period ) cross-over , double blind , double dummy , placebo control study compare levocetirizine cetirizine mean IR thermography .</brief_summary>
	<brief_title>Facial Thermography Study Levocetirizine Versus Cetirizine</brief_title>
	<detailed_description />
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Levocetirizine</mesh_term>
	<mesh_term>Cetirizine</mesh_term>
	<criteria>Healthy male Caucasian subject age 18 55 year ( inclusive ) . Subject must positive prick test histamine ( wheal diameter ≥ 6 mm histamine dihydrochloride ( 100 mg/mL ) ≤ 3 mm diluent control ) . History allergic disease , document suspect , include limited : asthma , whether consider allergic ; nocturnal cough episode suspect asthmaequivalent nature ( three consecutive night result sleep disturbance ) ; allergic rhinitis , conjunctivitis sinusitis ; nasal polyposis ; dermatitis face neck ; drug food allergy . Any clinically significant vascular disease hyper hypotension , venous disorder , vasculitis etc . History hot flush vasomotor disorder . ENT infection Upper Respiratory Tract Infection completely cure least one week inclusion . Any known history laryngeal edema . Nasal structural abnormality ( e.g . deviation nasal septum… ) . Recent immunotherapy Skin irritant UV exposure 48 hour visit .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Nasal histamine provocation , facial thermography , levocetirizine , cetirizine ,</keyword>
	<keyword>Xyzal , Zyrtec</keyword>
</DOC>